WuXi AppTec, a leading global pharmaceutical and medical device company, announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey.
The new facility will enhance WuXi’s integrated testing service portfolio enabling drug developers to accelerate their projects from labs to patients. The expansion will double total operation space and will create over 200 jobs. After the expansion, LTD’s combined New Jersey operation will be one of the largest laboratories for preclinical and clinical drug development testing in the United States.
The new site will establish a center of excellence for drug development and provide high quality services to the US pharmaceutical and biotech industries. Furthermore, WuXi will recruit extensively from the local talent base, further contributing to economic growth locally.
Headquartered in Shanghai, China, WuXi AppTec is a global pharmaceutical and medical device open-access capability and technology platform company. In addition to the New Jersey site, WuXi also has U.S. facilities in Philadelphia, St. Paul, Atlanta, San Diego, Boston etc. WuXi’s continually growing global presence includes Germany, Israel, South Korea, Japan and beyond.